GNH USA

Europe — EMA

Lindynette 20 (Ethinylestradiol, Gestodene)

GNH USA supplies Lindynette 20 (Ethinylestradiol / Gestodene), a combined oral contraceptive for prevention of pregnancy. Request a quote for global supply.

Ethinylestradiol, Gestodene

Request sourcing

1
Pack/s

What is Ethinylestradiol, Gestodene?

Ethinylestradiol and Gestodene, the active ingredients in Lindynette 20, are a combined oral contraceptive presented as a 20 µg/75 µg oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Lindynette 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including Europe, Asia, Africa and the Americas. All batches are manufactured under EU GMP standards and undergo rigorous quality testing before release. The product is distributed through a secure cold‑chain logistics network to maintain integrity.

What is Ethinylestradiol, Gestodene used for?

Lindynette 20, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus in women of childbearing potential.

What are the side effects of Ethinylestradiol, Gestodene?

Lindynette 20 may cause a range of adverse reactions. Patients should be informed of both frequent and rare events.

Common Side Effects: - Nausea: mild stomach upset, especially at the start of therapy. - Headache: transient headaches may occur. - Breast tenderness: mild swelling or discomfort. - Spotting: irregular breakthrough bleeding.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis, pulmonary embolism, stroke. - Hepatic disorders: cholestatic jaundice or hepatic adenoma. - Severe allergic reactions: rash, angioedema, anaphylaxis.

What precautions apply to Ethinylestradiol, Gestodene?

Before prescribing Lindynette 20, clinicians should consider several safety aspects.

- Assess thrombotic risk: review history of venous or arterial clotting, smoking, hypertension. - Evaluate contraindications: avoid in pregnancy, known estrogen‑dependent tumors, active liver disease. - Monitor blood pressure: ensure hypertension is controlled before initiating. - Counsel on smoking: advise cessation, especially in women over 35. - Review medication list: check for interacting drugs that may increase estrogen levels. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

What does Ethinylestradiol, Gestodene interact with?

Lindynette 20 can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital): reduce contraceptive efficacy. - Rifampicin and other strong CYP3A4 inducers: may lead to contraceptive failure. - Additional estrogen‑containing products (hormone replacement therapy, estrogen‑containing patches): increase risk of thromboembolism.

Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole: may increase plasma levels of estrogen. - Certain antibiotics (e.g., clarithromycin) and antivirals: may modestly affect hormone metabolism.

Frequently asked questions

What is Lindynette 20 used for?+
Lindynette 20 is a combined oral contraceptive tablet indicated for the prevention of pregnancy in women of reproductive age. It works by inhibiting ovulation and creating cervical mucus conditions that are unfavorable for sperm penetration and implantation.
How does ethinyloestradiol/gestodene work?+
Ethinyloestradiol provides estrogenic activity while gestodene supplies progestogenic activity. Together they suppress the hypothalamic‑pituitary‑ovarian axis, preventing the LH and FSH surge needed for ovulation, and they also thicken cervical mucus and alter the endometrium to reduce the chance of implantation.
What is the usual dose of Lindynette 20?+
The dosing regimen for Lindynette 20 is determined by the prescribing healthcare professional. Typically, it involves taking one tablet daily for a defined cycle, often 21 active tablets followed by a 7‑day hormone‑free interval, but the exact schedule should follow the prescriber’s instructions.
Is Lindynette 20 safe during pregnancy or breastfeeding?+
Lindynette 20 is not intended for use during pregnancy and should be discontinued if pregnancy occurs. Limited data exist for breastfeeding; while some combined oral contraceptives are considered compatible after the first six weeks postpartum, the decision should be made by a healthcare provider based on individual risk‑benefit assessment.
How do I order Lindynette 20 from GNH USA?+
To order Lindynette 20, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lindynette 20 compare with other combined oral contraceptives?+
Lindynette 20 contains a low‑dose estrogen (20 µg ethinyloestradiol) combined with gestodene, a third‑generation progestogen known for a favorable bleeding profile. Compared with older formulations that use higher estrogen doses or first‑generation progestins, Lindynette 20 may offer reduced estrogen‑related side effects while maintaining contraceptive efficacy.
How should Lindynette 20 be stored and handled?+
Store Lindynette 20 at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct light, and discard any tablets that are discolored or past their expiry date.
How is Lindynette 20 administered?+
Lindynette 20 is taken orally with water, preferably at the same time each day. The tablet should be swallowed whole and not split, chewed, or crushed. Consistency in timing helps maintain stable hormone levels and maximizes contraceptive effectiveness.
What are the most serious risks associated with Lindynette 20?+
The most serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Hepatic complications like cholestatic jaundice or hepatic adenoma and severe allergic reactions (e.g., anaphylaxis) are also rare but potentially life‑threatening.
Who should not use Lindynette 20?+
Lindynette 20 is contraindicated in women who are pregnant, have known or suspected estrogen‑dependent tumors, have active liver disease, have a history of thromboembolic disorders, are smokers over 35 years of age, or have uncontrolled hypertension. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ethinylestradiol, Gestodene
Route
Oral Use
Manufacturer
Gedeon Richter Plc.
Origin
EU

Related products

Akizza

Akizza

Ethinylestradiol, Gestodene

Morningside Healthcare Ltd
EU
Alessia

Alessia

Ethinylestradiol, Gestodene

Hexal Ag
EU
Artilla

Artilla

Ethinylestradiol, Gestodene

Zentiva, K.S.
EU
Artizia

Artizia

Ethinylestradiol, Gestodene

Zentiva, K.S.
EU